Cat.#: ACPP-1346
| Despition | GFAP Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1699 | Human Human Prealbumin (Active) Protein (AC1699) | 1 mg | inquiry |
| ACPP-1034 | Recombinant Human NG2 Protein (6×His Tag) (AC1034) | 50 µg | inquiry |
| ACPP-1372 | Exendin 4 (AC1372) | 20 µg | inquiry |
| ACPP-1449 | Human IL 6 Protein, CHO (AC1449) | 5 µg | inquiry |
| ACPP-1062 | Recombinant Human TYRO3 Protein (Fc Tag) (AC1062) | 50 µg | inquiry |
| ACPP-1014 | Recombinant Human P Cadherin Protein (6×His Tag) (AC1014) | 50 µg | inquiry |
| ACPP-1403 | Human Insulin (Active) Protein (AC1403) | 1 mg | inquiry |
| ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
| ACPP-1415 | Human GNAQ Protein (AC1415) | 5 µg | inquiry |
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.